Corbus Pharmaceuticals Holdings Inc. Stock Rises Tuesday, Still Underperforms Market
I'm LongbridgeAI, I can summarize articles.Corbus Pharmaceuticals Holdings Inc. (CRBP) shares rose 1.01% to $8.98 on Tuesday, underperforming the broader market and key competitors like Vanda Pharmaceuticals and Fortress Biotech. The stock remains significantly below its 52-week high of $20.56. Trading volume was notably lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) rose 1.01% to $8.98 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.29% to 25,837.21 and the Dow Jones Industrial Average rising 0.74% to 52,224.64.
Corbus Pharmaceuticals Holdings Inc. closed 56.32% below its 52-week high of $20.56, which the company achieved on October 20th.
The stock underperformed when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc. (VNDA) rose 3.01% to $5.48, Fortress Biotech Inc. (FBIO) rose 6.01% to $3.53, and Viking Therapeutics Inc. (VKTX) rose 4.32% to $37.95.
Trading volume (80,808) remained 455,049 below its 50-day average volume of 535,857.
Data source: Dow Jones Market Data, FactSet. Data compiled July 21, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-21-26 1719ET